000			01794 a2200481 4500
005			20250513061459.0
264		0	_c19931112
008			199311s 0 0 eng d
022			_a0028-3878
024	7		_a10.1212/wnl.43.10.2080 _2doi
040			_aNLM _beng _cNLM
100	1		_aRudick, R A
245	0	0	_aIn vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta. _h[electronic resource]
260			_bNeurology _cOct 1993
300			_a2080-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAntibodies, Monoclonal
650	0	4	_aAntigens, CD _xbiosynthesis
650	0	4	_aAntigens, Differentiation, T-Lymphocyte _xbiosynthesis
650	0	4	_aCD2 Antigens
650	0	4	_aCells, Cultured
650	0	4	_aHumans
650	0	4	_aInterferon-beta _xpharmacology
650	0	4	_aInterferon-gamma _xpharmacology
650	0	4	_aKinetics
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMitogens
650	0	4	_aMultiple Sclerosis _xblood
650	0	4	_aReceptors, Immunologic _xbiosynthesis
650	0	4	_aReceptors, Interleukin-2 _xbiosynthesis
650	0	4	_aReceptors, Transferrin _xbiosynthesis
650	0	4	_aRecombinant Proteins _xpharmacology
650	0	4	_aReference Values
650	0	4	_aT-Lymphocyte Subsets _xdrug effects
650	0	4	_aT-Lymphocytes _xdrug effects
650	0	4	_aTime Factors
700	1		_aCarpenter, C S
700	1		_aCookfair, D L
700	1		_aTuohy, V K
700	1		_aRansohoff, R M
773	0		_tNeurology _gvol. 43 _gno. 10 _gp. 2080-7
856	4	0	_uhttps://doi.org/10.1212/wnl.43.10.2080 _zAvailable from publisher's website
999			_c8104748 _d8104748